This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ nsaid

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Gastrointestinal Effects: NSAIDs can irritate the lining of the stomach and increase the risk of developing ulcers and gastrointestinal bleeding. This risk is higher in individuals with a history of stomach ulcers, gastrointestinal bleeding, or those who take NSAIDs at high doses or for long periods.

  2. Cardiovascular Effects: Some NSAIDs, particularly certain selective COX-2 inhibitors, have been associated with an increased risk of cardiovascular events such as heart attack and stroke. The risk may vary depending on factors such as the specific NSAID used, dosage, duration of use, and individual cardiovascular risk factors.

  3. Renal (Kidney) Effects: NSAIDs can impair kidney function and may lead to kidney damage, particularly in individuals with pre-existing kidney disease or those who are dehydrated. Long-term use of NSAIDs can also increase the risk of developing chronic kidney disease.

  4. Hepatic (Liver) Effects: Rarely, NSAIDs can cause liver damage or liver failure, especially when taken at high doses or in combination with other medications that affect the liver. It's important to monitor liver function regularly, especially in individuals with pre-existing liver conditions.

  5. Fluid Retention and Hypertension: NSAIDs may cause fluid retention and lead to elevated blood pressure, particularly in individuals with hypertension or heart failure.

  6. Gastrointestinal Symptoms: Common gastrointestinal side effects of NSAIDs include dyspepsia (indigestion), nausea, vomiting, abdominal pain, and diarrhea.

  7. Allergic Reactions: Some individuals may experience allergic reactions to NSAIDs, ranging from mild skin rashes to severe anaphylaxis. People with known allergies to NSAIDs or asthma are at higher risk.

  8. Gastrointestinal Perforation: In rare cases, NSAIDs can cause perforation or a hole in the stomach or intestines, leading to a medical emergency.

  9. Increased Bleeding Risk: NSAIDs can impair platelet function and prolong bleeding time, which may increase the risk of bleeding, particularly in individuals with bleeding disorders or those taking blood-thinning medications.

  10. Interaction with Other Medications: NSAIDs may interact with other medications, including blood thinners, certain antidepressants, and some blood pressure medications, potentially increasing the risk of adverse effects.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

Data Contradictions — Limits of Certainity

Impacted of nsaid On Probiotics

Rank Probiotic Impact

Bacteria Impacted by nsaid

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
1 0 Acidaminococcaceae family Increases
1 0 Desulfovibrionaceae family Increases
1 0 Enterococcaceae family Increases
1 0 Erysipelotrichaceae family Increases
0 1 Faecalibacillus genus Increases
0 1 Vagococcus genus Increases
0 1 Allobaculum genus Increases
0 1 Tetragenococcus genus Increases
0 1 Tannockella genus Increases
0 1 Pseudodesulfovibrio genus Increases
0 1 Lawsonia genus Increases
0 1 Oceanidesulfovibrio genus Increases
0 1 Oleidesulfovibrio genus Increases
0 1 Allocoprobacillus genus Increases
0 1 Erysipelothrix genus Increases
0 1 Solidesulfovibrio genus Increases
0 1 Desulfolutivibrio genus Increases
0 1 Megalodesulfovibrio genus Increases
0 1 Faecalibaculum genus Increases
0 1 Bulleidia genus Increases
0 1 Acidaminococcus genus Increases
0 1 Intestinibaculum genus Increases
0 1 Catenibacterium genus Increases
0 1 Amedibacterium genus Increases
0 1 Desulfovibrio genus Increases
0 1 Longicatena genus Increases
0 1 Faecalitalea genus Increases
0 1 Maridesulfovibrio genus Increases
0 1 Absicoccus genus Increases
0 1 Absiella genus Increases
0 1 Amedibacillus genus Increases
0 1 Anaerorhabdus genus Increases
0 1 Beduini genus Increases
0 1 Breznakia genus Increases
0 1 Candidatus Stoquefichus genus Increases
0 1 Catellicoccus genus Increases
0 1 Catenisphaera genus Increases
0 1 Copranaerobaculum genus Increases
0 1 Coprobacillus genus Increases
0 1 Desulfobaculum genus Increases
0 1 Desulfocurvibacter genus Increases
0 1 Desulfocurvus genus Increases
0 1 Desulfohalovibrio genus Increases
0 1 Dielma genus Increases
0 1 Eggerthia genus Increases
0 1 Erysipelatoclostridium genus Increases
0 1 Faecalicoccus genus Increases
0 1 Fundidesulfovibrio genus Increases
0 1 Halodesulfovibrio genus Increases
0 1 Holdemanella genus Increases
0 1 Holdemania genus Increases
0 1 Humidesulfovibrio genus Increases
0 1 Ileibacterium genus Increases
0 1 Kandleria genus Increases
0 1 Longibaculum genus Increases
0 1 Mailhella genus Increases
0 1 Massilicoli genus Increases
0 1 Massilimicrobiota genus Increases
0 1 Melissococcus genus Increases
0 1 Merdibacter genus Increases
0 1 Nitratidesulfovibrio genus Increases
0 1 Paradesulfovibrio (ex Waite et al. 2020) genus Increases
0 1 Paucidesulfovibrio genus Increases
0 1 Pilibacter genus Increases
0 1 Salidesulfovibrio genus Increases
0 1 Solobacterium genus Increases
0 1 Succiniclasticum genus Increases
0 1 Succinispira genus Increases
0 1 Traorella genus Increases
0 1 Phascolarctobacterium genus Increases
0 1 Bilophila genus Increases
0 1 Enterococcus genus Increases
0 1 Turicibacter genus Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 Erysipelotrichaceae incertae sedis no rank Increases
0 1 unclassified Acidaminococcaceae no rank Increases
0 1 unclassified Desulfovibrionaceae no rank Increases
0 1 unclassified Enterococcaceae no rank Increases
0 1 unclassified Erysipelotrichaceae no rank Increases
0 1 Lactobacillales order Increases
0 1 Erysipelotrichales order Increases
0 1 Desulfovibrionales order Increases
0 1 Acidaminococcales order Increases

Impact of nsaid on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 -0.6
Acne 0.3 0.3
ADHD 0.6 0.8 -0.33
Allergic Rhinitis (Hay Fever) 0.6 -0.6
Allergies 2.4 1.5 0.6
Allergy to milk products 1.8 1.8
Alopecia (Hair Loss) 1.1 0.6 0.83
Alzheimer's disease 2 5.4 -1.7
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.2 0.2
Ankylosing spondylitis 0.2 -0.2
Anorexia Nervosa 0 0
Antiphospholipid syndrome (APS) 0.6 0.6
Asthma 1.2 0.9 0.33
Atherosclerosis 0 0
Atrial fibrillation 1.4 1.1 0.27
Autism 3 2.3 0.3
Autoimmune Disease 1.2 -1.2
Barrett esophagus cancer 0.9 0.9
Bipolar Disorder 1.2 0.6 1
Brain Trauma 0.6 0.2 2
Breast Cancer 0 0
Cancer (General) 0.2 -0.2
Carcinoma 0.1 0.9 -8
Celiac Disease 1.1 1.6 -0.45
Cerebral Palsy 0.6 -0.6
Chronic Fatigue Syndrome 0.6 2.6 -3.33
Chronic Kidney Disease 0.6 1.6 -1.67
Chronic Obstructive Pulmonary Disease (COPD) 0.6 1.2 -1
Chronic Urticaria (Hives) 0 0
Coagulation / Micro clot triggering bacteria 0 0
Cognitive Function 0.9 1.3 -0.44
Colorectal Cancer 1.4 2.8 -1
Coronary artery disease 0.9 2 -1.22
COVID-19 0.6 2.9 -3.83
Crohn's Disease 2 2.3 -0.15
Cushing's Syndrome (hypercortisolism) 0.6 -0.6
cystic fibrosis 0.3 0.6 -1
deep vein thrombosis 0.6 0.6 0
Denture Wearers Oral Shifts 0.6 -0.6
Depression 1.5 4.6 -2.07
Eczema 0.6 -0.6
Endometriosis 0.6 0.6 0
Epilepsy 0.9 -0.9
erectile dysfunction 0.6 -0.6
Fibromyalgia 0.5 -0.5
Functional constipation / chronic idiopathic constipation 0.2 1.4 -6
Generalized anxiety disorder 0.2 1.1 -4.5
giant cell arteritis 0.2 0.2
Glioblastoma 0.5 0.5
Gout 2.4 -2.4
Graves' disease 0.8 -0.8
Gulf War Syndrome 0.6 -0.6
Halitosis 0.3 -0.3
Hashimoto's thyroiditis 1.8 1.7 0.06
Heart Failure 1.8 -1.8
hemorrhagic stroke 0.7 -0.7
Hemorrhoidal disease, Hemorrhoids, Piles 0.5 0.5
Hidradenitis Suppurativa 0.8 -0.8
hypercholesterolemia (High Cholesterol) 1.2 0 0
hyperglycemia 0.2 0.6 -2
Hyperlipidemia (High Blood Fats) 2 -2
hypersomnia 0.6 0.6
hypertension (High Blood Pressure 3.2 2.3 0.39
Hypothyroidism 0.3 -0.3
Hypoxia 0.8 -0.8
IgA nephropathy (IgAN) 1.2 0.6 1
Inflammatory Bowel Disease 0.5 2 -3
Insomnia 0 0.6 0
Intelligence 0.1 0.1
Intracranial aneurysms 0 0.3 0
Irritable Bowel Syndrome 2.2 3.7 -0.68
Juvenile idiopathic arthritis 0.4 0.4
Liver Cirrhosis 2.7 2.5 0.08
Long COVID 3.1 3.7 -0.19
Low bone mineral density 0.5 0.5
Lung Cancer 0.6 -0.6
Lymphoma 1.7 1.7
ME/CFS with IBS 0.6 0.6 0
ME/CFS without IBS 0.6 0.9 -0.5
Metabolic Syndrome 3.6 4.1 -0.14
Mood Disorders 2.4 4.3 -0.79
multiple chemical sensitivity [MCS] 0.6 0.6
Multiple Sclerosis 1.5 1.3 0.15
Multiple system atrophy (MSA) 0.5 0.5 0
neuropathic pain 0.6 0.6
Neuropathy (all types) 0.5 -0.5
neuropsychiatric disorders (PANDAS, PANS) 1.2 1.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1 2.8 -1.8
Obesity 3.4 4.3 -0.26
obsessive-compulsive disorder 0.6 0.9 -0.5
Osteoarthritis 0.5 0.3 0.67
Osteoporosis 0.8 0.8
pancreatic cancer 0.6 -0.6
Parkinson's Disease 1.1 5.2 -3.73
Polycystic ovary syndrome 0.8 2 -1.5
primary biliary cholangitis 1.2 0.7 0.71
Primary sclerosing cholangitis 1 0.6 0.67
Psoriasis 0.3 1.1 -2.67
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.4 4.3 -0.79
Rosacea 0 0.6 0
Schizophrenia 1.8 2.6 -0.44
scoliosis 0.6 0.1 5
Sleep Apnea 0.6 0.6
Small Intestinal Bacterial Overgrowth (SIBO) 0.8 -0.8
Stress / posttraumatic stress disorder 0.5 2.2 -3.4
Systemic Lupus Erythematosus 0.2 1.8 -8
Tic Disorder 0.1 0.3 -2
Type 1 Diabetes 0.6 1.2 -1
Type 2 Diabetes 1.2 3.5 -1.92
Ulcerative colitis 2 2 0
Unhealthy Ageing 1.6 -1.6
Vitiligo 0.1 -0.1

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]